Skip to Content

CASI Pharmaceuticals Inc CASI Stock Quote

| Rating as of

NASDAQ: CASI

Market Closed

| Currency in USD

  • Last Close 2.15
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Value
  • Day Range 2.00  –  2.19
  • Year Range 1.45  –  3.70
  • Market Cap 28.6412 Mil
  • Volume / Avg 23,197.0 /  12,454.3
  • Price / Sales 0.68
  • Price / Book 0.65
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis CASI

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CASI

Company Profile CASI

Business Description

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world.

Contact
9620 Medical Center Drive, Suite 300
Rockville, MD, 20850
Industry Biotechnology
Employees 224

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of CASI’s competitive advantage.

CASI Pharmaceuticals Inc

XNAS: CASI

Pfizer Inc

XNYS: PFE
Price
2.1532.69
Currency
USDUSD
Change
+$0.15 (7.50%) −$0.16 (0.49%)
Market Cap
28.64 Mil184.57 Bil
Industry
Biotechnology Drug Manufacturers - General
Sector
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for CASI Pharmaceuticals Inc Stock

No. CASI does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CASI’s market cap is 28.64 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CASI’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CASI’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CASI’s historical performance against its industry peers and the overall market.